ArticleFrontiers in genetics2026
From ISO 9001:2015 to ISO 20387:2018: a proposed implementation roadmap for biobanks.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Biobanks play an important role in biomedical research because of the availability of vast quantities of high-quality biological specimens and related data. However, biobank-specific standards such as ISO 20387:2018 have been infrequently implemented. This study aimed to develop a practical implementation roadmap to assist ISO 9001:2015-certified biobanks in adopting ISO 20387:2018. Methods: The implementation roadmap was developed through a scientific literature review and a comparative, clause-level analysis (crosswalk) of ISO 9001:2015 and ISO 20387:2018. The analysis identified areas of overlap between the standards and requirements specific to ISO 20387:2018. Results: The crosswalk demonstrated substantial overlap between the two standards while identifying additional ISO 20387:2018 requirements related to financial viability assessment, plans for future expansion, additional specimen-collection standards, authentication protocols, and reporting requirements. Based on these findings, we developed a practical, time-bound implementation framework that leverages existing ISO 9001:2015 systems to help structure the transition to ISO 20387:2018. The proposed roadmap can be completed within an estimated 17-20 weeks. Discussion/Conclusion: The implementation framework provides a structured approach for ISO 9001:2015-certified biobanks seeking to adopt ISO 20387:2018 and may help make accreditation more attainable for resource-constrained biobanks. We identify testable assumptions about feasibility, duration, and organizational benefits, and highlight the need for formal training in biobank management to sustain implementation. Prospective validation is needed to determine whether the proposed timeline and anticipated organizational benefits are achieved in practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.